China’s New Drug Procurement Program Shakes Up Big Pharma
The new bidding system for generic drugs upends the business of global drug makers in China. The big winners have been Chinese drug makers.
Meet the Military Affiliates
Trump’s November executive order branded 31 companies as having ties to the People’s Liberation Army. Who are they, and who has stakes in them?
Mining’s Makeover
For more than a decade, the U.S. has been sounding the alarm about China’s stranglehold on rare earths. Now with new investments and new operations...
Delivering China’s Mail
How did USPS end up subsidizing China’s e-commerce?
China’s Auction Houses
The global auction market has long been dominated by Sotheby’s and Christie’s, but China Guardian and Poly Auction are catching up.
China’s Open Source Problem
It’s part of the Internet you can’t “splinter.”
Ant Group’s Long March
Ant has been a force for financial inclusion. Regulator concerns must be weighed against the value that fintech innovations offer to society.
The Samsung Sandwich
The Korean giant was one of the first multinationals to build a huge presence in China, pumping billions of dollars into the country and eventually...
Clouded Judgement
China’s cloud services are expected to balloon in coming years, but U.S. firms like Google, Amazon and Microsoft face tricky decisions about entering the market.
China and the U.S. Entity List
Foreign entities are often placed on the U.S. Entity List. But many of their subsidiaries and affiliates are not. Is that a problem?
Miniso’s Moment?
After a big NYSE debut, the Chinese retailer could face an uphill battle.
The PLA’s Unlikely Wingman
AVIC, China’s aerospace behemoth, has been known to steal U.S. trade secrets. But it's also been allowed to buy them. After the 2008 financial crisis,...